Immediate-release, liquid oral pharmaceutical suspension dosage form of eslicarbazepine acetate

GB2703902APending Publication Date: 2026-08-12SAPTALIS PHARM LLC

View PDF 2 Cites 0 Cited by

Patent Information

Authority / Receiving Office: GB · GB
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-12-15
Publication Date: 2026-08-12

Application Information

Patent Timeline

15 Dec 2025

Application

12 Aug 2026

Publication

GB2703902A

IPC: A61K31/55; A61K9/08; A61K9/10; A61K47/32; A61K47/38; A61P25/00

CPC: A61K31/55; A61K47/32; A61K9/08; A61K47/38; A61K9/10; A61P25/00

Inventors: LARISA KUZNETSOVA; POLIREDDY DONDETI

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 00000001_0000
Figure 00000001_0001

Patent Text Reader

Abstract

An immediate-release, liquid oral pharmaceutical suspension dosage form comprising eslicarbazepine acetate or a pharmaceutically acceptable salt, ester, hydrate or polymorph thereof in an amount 5-10g

Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

ViewUS2020/222420A1onEspacenetopensinnewtab
ViewUS2021/275539A1onEspacenetopensinnewtab

Patent Information

Abstract

Patent Citations

ViewUS2020/222420A1onEspacenetopensinnewtab

ViewUS2021/275539A1onEspacenetopensinnewtab